Drugs / CAR-M
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07409766 | Jan 2026 → Dec 2028 expected | cancer | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-M | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07409766 ↗ |
| Modality | Cell therapy | “CAR-M (chimeric antigen receptor-macrophage)” NCT07409766 ↗ |